Literature DB >> 18360041

Adiponectin levels associated with the development of hypertension: a prospective study.

Takuya Imatoh1, Motonobu Miyazaki, Yoshito Momose, Shinichi Tanihara, Hiroshi Une.   

Abstract

Adiponectin is a recently discovered protein that seems to be exclusively secreted by adipocytes and is the most abundant adipose tissue-derived protein. While some recent studies have demonstrated an association between adiponectin levels and hypertension, these studies were cross-sectional in design, and the results have been inconsistent. Therefore we performed a prospective study to elucidate the role of adiponectin in the development of hypertension. The results of this study showed that serum adiponectin levels were significantly lower in hypertensive subjects than in normotensive subjects. Moreover, in logistic regression analysis, the subjects in the lowest quartile had a 3.72-fold higher risk than those in the highest quartile. Even after adjusting for potential confounding factors, this association was found to be significant. Low serum adiponectin levels were found to be independently associated with a higher risk for the development of hypertension. Our results therefore suggest that hypoadiponectinemia is a novel predictor of hypertension.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18360041     DOI: 10.1291/hypres.31.229

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  27 in total

1.  Sex differences in the regulation of porcine coronary artery tone by perivascular adipose tissue: a role of adiponectin?

Authors:  Abdulla A Ahmad; Michael D Randall; Richard E Roberts
Journal:  Br J Pharmacol       Date:  2017-07-12       Impact factor: 8.739

Review 2.  Adiponectin and cardiovascular health: an update.

Authors:  Xiaoyan Hui; Karen S L Lam; Paul M Vanhoutte; Aimin Xu
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

3.  Serum adiponectin complexes and cardiovascular risk in children with chronic kidney disease.

Authors:  Megan M Lo; Shelia Salisbury; Philipp E Scherer; Susan L Furth; Bradley A Warady; Mark M Mitsnefes
Journal:  Pediatr Nephrol       Date:  2011-05-08       Impact factor: 3.714

4.  Metabolic and hormonal changes induced by pioglitazone in polycystic ovary syndrome: a randomized, placebo-controlled clinical trial.

Authors:  Vanita R Aroda; Theodore P Ciaraldi; Paivi Burke; Sunder Mudaliar; Paul Clopton; Susan Phillips; R Jeffrey Chang; Robert R Henry
Journal:  J Clin Endocrinol Metab       Date:  2008-11-04       Impact factor: 5.958

5.  Adiponectin protects against incident hypertension independent of body fat distribution: observations from the Dallas Heart Study.

Authors:  Poghni A Peri-Okonny; Colby Ayers; Naim Maalouf; Sandeep R Das; James A de Lemos; Jarett D Berry; Aslan T Turer; Ian J Neeland; Philipp E Scherer; Wanpen Vongpatanasin
Journal:  Diabetes Metab Res Rev       Date:  2016-08-18       Impact factor: 4.876

6.  Hypoadiponectinemia as an independent predictor for the progression of carotid atherosclerosis: a 5-year prospective study.

Authors:  Elaine Hui; Aimin Xu; Wing-Sun Chow; Paul C H Lee; Carol H Y Fong; Stephen C W Cheung; Hung Fat Tse; Ming-Tak Chau; Bernard M Y Cheung; Karen S L Lam
Journal:  Metab Syndr Relat Disord       Date:  2014-09-11       Impact factor: 1.894

7.  Plasma adiponectin and the risk of hypertension in white and black postmenopausal women.

Authors:  Lu Wang; JoAnn E Manson; J Michael Gaziano; Simin Liu; Barbara Cochrane; Nancy R Cook; Paul M Ridker; Nader Rifai; Howard D Sesso
Journal:  Clin Chem       Date:  2012-08-02       Impact factor: 8.327

8.  Association between adipocytokines and insulin resistance in Indian hypertensive patients.

Authors:  Sujata R Mahadik
Journal:  Indian Heart J       Date:  2012-03-26

Review 9.  Adiponectin levels and the risk of hypertension: a systematic review and meta-analysis.

Authors:  Dae Hyun Kim; Chul Kim; Eric L Ding; Mary K Townsend; Lewis A Lipsitz
Journal:  Hypertension       Date:  2013-05-28       Impact factor: 10.190

Review 10.  Obesity, Adipose Tissue and Vascular Dysfunction.

Authors:  Mascha Koenen; Michael A Hill; Paul Cohen; James R Sowers
Journal:  Circ Res       Date:  2021-04-01       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.